Monday, April 22, 2013 11:14:21 AM
Preferred shares are a hybrid instrument, having characteristics of a bond, i.e. a Redemption Value (or Face Value), and that of an equity security (i.e. some are convertible into common stock). In this instance, there is no conversion clause in the prospectus for the Preferred Securities (as of my reading of the FMCKL prospectus).
Thus, Preferred shares have the following pros: (1) they provide a dividend (in nominal circumstances). (2) they are senior to all other equity interests (i.e. we get paid first).
They also have the following major con: (1) Max value is the Redemption value (i.e. they do not participate in the companies growth outside of the dividends) and (2) they can be "called" or redeemed by the company for face value.
These share a similar risk characteristic to convertible bonds, but with lower priority (someone else who is experienced in distressed debt can chime in here to clarify if I'm wrong).
Thus, preferred shares are typically a safer bet in special situations, because they have a lower risk profile (i.e. we're paid first) vs common equity.
Basically, at current prices, the "Market" or what is supposed to approximate it on the pink sheets, is saying that the preferred classes have a roughly 20% shot of being fully redeemed, or partially redeemed at 20% of FV (RV).
I have no clear way to value the commons at this point, since FnF are not really going concerns (in the classical, easy to understand sense... no flame posts please), and as others have stated, the USG is sitting on a ton of warrants for common stock.
Since I don't have a clear view of how to value the commons, I went with the more conservative distressed situation bet and invested with preferred shares.
Thus, to my mind, the market is showing exactly what it should: Preferreds are the safer bet in special situations and are valued higher in accordance with this.
Best,
Jared
Recent FNMAS News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:07:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:05:24 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM